GALE
vs
Swiss Market Index
Over the past 12 months, GALE has underperformed Swiss Market Index, delivering a return of 3% compared to the Swiss Market Index's 6% growth.
Stocks Performance
GALE vs Swiss Market Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
IT |
Amplifon SpA
MIL:AMP
|
Performance Gap
GALE vs Swiss Market Index
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
IT |
Amplifon SpA
MIL:AMP
|
Performance By Year
GALE vs Swiss Market Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
IT |
Amplifon SpA
MIL:AMP
|
Competitors Performance
Galenica AG vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
Schlumberger NV
NYSE:SLB
|
||
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
||
US |
R
|
Reddit Inc
NYSE:RDDT
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
|
US |
Halliburton Co
NYSE:HAL
|
||
LU |
Tenaris SA
MIL:TEN
|
||
IN |
Jio Financial Services Ltd
NSE:JIOFIN
|
Galenica AG
Glance View
In the picturesque landscape of Switzerland, Galenica AG operates as a stalwart in the healthcare sector, seamlessly bridging the gap between pharmaceutical production and retail distribution. Born from a deep-rooted legacy in delivering health solutions, Galenica combines its prowess in logistics with an extensive network of pharmacies spread across the country. The magic of Galenica's operations lies in its unique dual structure. On one hand, it operates a robust logistics arm, supplying a wide array of medicines to healthcare providers, hospitals, and pharmacies. On the other hand, it runs its own retail pharmacy chains, such as Amavita and Sun Store, alongside an e-commerce platform, which make pharmaceutical care more accessible and customer-friendly for the Swiss populace. Galenica's profitability thrives on this diversified business model. By owning the supply chain from logistics to retail, the company maximizes efficiency and reduces costs, positioning itself as a leader in the Swiss pharmaceutical market. Revenue streams flow from wholesale distribution contracts, retail pharmacy sales, and a growing presence in digital health services. Furthermore, in its operations, Galenica integrates a customer-centric philosophy, leveraging data analytics to optimize stock management and personalize customer experiences—effectively enhancing earnings and customer loyalty. Through meticulous execution and strategic expansion, Galenica ensures that it remains an indispensable player in Switzerland's healthcare framework.